Skip Navigation


Hum. Reprod. Advance Access originally published online on December 22, 2007
Human Reproduction 2008 23(3):481-492; doi:10.1093/humrep/dem327
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
23/3/481    most recent
dem327v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Goossens, V.
Right arrow Articles by Sermon, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goossens, V.
Right arrow Articles by Sermon, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

fast track

Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis

Veerle Goossens1,{dagger}, Martine De Rycke1,2,{dagger}, Anick De Vos3,{dagger}, Catherine Staessen1,2, An Michiels2, Willem Verpoest3, André Van Steirteghem1,3, Catherine Bertrand4, Inge Liebaers1,2, Paul Devroey1,3 and Karen Sermon1,2,5

1 Department of Embryology and Genetics, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium 2 Centre for Medical Genetics, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium 3 Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium 4 Veeda Clinical Research, Koning Albertlaan 160, 1082 Brussels, Belgium

5 Correspondence address. Tel: +32-2-477-60-73; Fax: +32-2-477-68-60; E-mail: karen.sermon{at}uzbrussel.be

BACKGROUND: Preimplantation genetic diagnosis or screening (PGD, PGS) involves embryo biopsy on Day 3. Opting for one- or two-cell biopsy is a balance between the lowest risk for misdiagnosis on the one hand and the highest chance for a pregnancy on the other hand.

METHODS: A prospective controlled trial was designed and 592 ICSI cycles were randomly assigned to the one-cell (group I) or the two-cell group (group II). Primary outcomes were diagnostic efficiency and embryonic development to delivery with live birth (analysed by cycle). The false-positive rate for the PCR cycles is presented as a secondary outcome (analysed by embryo).

RESULTS: A strong significant correlation was observed between embryonic developmental stage on Day 3 and post-biopsy in vitro development on Day 5 (P < 0.0001). The influence of the intervention on Day 3 was less significant (P = 0.007): the biopsy of one cell is less invasive than the biopsy of two cells. PCR diagnostic efficiency was 88.6% in group I and 96.4% in group II (P = 0.008). For the fluorescence in situ hybridization (FISH) PGD cycles no significant difference in efficiency was obtained (98.2 and 97.5% in group I and II, respectively). Similar delivery rates with live birth per started cycle were obtained [58/287 or 20.2% in group I versus 52/303 or 17.2% in group II, P = 0.358; the absolute risk reduction = 3.05%; 95% confidence interval (CI): –3.24, 9.34]. Post-PGD PCR reanalysis showed six false positives in 97 embryos (6.2%) in group II and none in group I (91 embryos reanalysed). No false negatives were found.

CONCLUSIONS: While removal of two blastomeres decreases the likelihood of blastocyst formation, compared with removal of one blastomere, Day 3 in vitro developmental stage is a stronger predictor for Day 5 developmental potential than the removal of one or two cells. The biopsy of only one cell significantly lowers the efficiency of a PCR-based diagnosis, whereas the efficiency of the FISH PGD procedure remains similar whether one or two cells are removed. Delivery rates with live birth per started cycle were not significantly different.

Key words: preimplantation genetic diagnosis/preimplantation genetic screening/embryo biopsy/embryo development/diagnostic efficiency


{dagger} The first three authors have equally contributed.

Submitted on May 8, 2007; resubmitted on August 13, 2007; accepted on September 20, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
A. De Vos, C. Staessen, M. De Rycke, W. Verpoest, P. Haentjens, P. Devroey, I. Liebaers, and H. Van de Velde
Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers
Hum. Reprod., December 1, 2009; 24(12): 2988 - 2996.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Hanson, T. Hardarson, K. Lundin, C. Bergh, T. Hillensjo, J. Stevic, C. Westin, U. Selleskog, L. Rogberg, and M. Wikland
Re-analysis of 166 embryos not transferred after PGS with advanced reproductive maternal age as indication
Hum. Reprod., November 1, 2009; 24(11): 2960 - 2964.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. Liebaers, S. Desmyttere, W. Verpoest, M. De Rycke, C. Staessen, K. Sermon, P. Devroey, P. Haentjens, and M. Bonduelle
Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis
Hum. Reprod., August 27, 2009; (2009) dep298v1.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Devroey, B.C.J.M. Fauser, K. Diedrich, and on behalf of the Evian Annual Reproduction (EVAR)
Approaches to improve the diagnosis and management of infertility
Hum. Reprod. Update, July 1, 2009; 15(4): 391 - 408.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Vanneste, C. Melotte, S. Debrock, T. D'Hooghe, H. Brems, J.P. Fryns, E. Legius, and J.R. Vermeesch
Preimplantation genetic diagnosis using fluorescent in situ hybridization for cancer predisposition syndromes caused by microdeletions
Hum. Reprod., June 1, 2009; 24(6): 1522 - 1528.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Wilton, A. Thornhill, J. Traeger-Synodinos, K.D. Sermon, and J.C. Harper
The causes of misdiagnosis and adverse outcomes in PGD
Hum. Reprod., May 1, 2009; 24(5): 1221 - 1228.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Ubaldi and L. Rienzi
Possible impact of LH-containing gonadotrophins on diploidy rates in preimplantation embryos
Hum. Reprod., May 1, 2009; 24(5): 1238 - 1239.
[Full Text] [PDF]


Home page
Hum ReprodHome page
A. Weghofer, S. Munne, W. Brannath, D.H. Barad, J. Cohen, and N. Gleicher
Reply: Possible impact of LH-containing gonadotrophins on diploidy rates in preimplantation embryos
Hum. Reprod., May 1, 2009; 24(5): 1239 - 1240.
[Full Text] [PDF]


Home page
Hum ReprodHome page
H. Van de Velde, M. De Rycke, C. De Man, K. De Hauwere, F. Fiorentino, S. Kahraman, G. Pennings, W. Verpoest, P. Devroey, and I. Liebaers
The experience of two European preimplantation genetic diagnosis centres on human leukocyte antigen typing
Hum. Reprod., March 1, 2009; 24(3): 732 - 740.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Yakin and B. Urman
What next for preimplantation genetic screening? A clinician's perspective
Hum. Reprod., August 1, 2008; 23(8): 1686 - 1690.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.